Erythropoietin enhances oxygenation in critically perfused tissue through modulation of nitric oxide synthase

Shock

Volumn 31, Issue 6, 2009, Pages 599-606

  Contaldo, Claudio ^a   Elsherbiny, Ahmed ^a   Lindenblatt, Nicole ^a   Plock, Jan A ^b   Trentz, Otmar ^a   Giovanoli, Pietro ^a   Menger, Michael D ^c   Wanner, Guido A ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c SAARLAND UNIVERSITY   (Germany)

Author keywords

eNOS; EPO; Hypoxia; Inflammation; Intravital microscopy; Ischemia; Microcirculation

Indexed keywords

N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PROTEIN; RECOMBINANT ERYTHROPOIETIN; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD FLOW; BODY WEIGHT; CELL COUNT; CELL NUCLEUS; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; HYPOXIA; INFLAMMATION; ISCHEMIA; MALE; MOUSE; NONHUMAN; OXYGEN TISSUE LEVEL; PROTEIN EXPRESSION; SKIN; SYRIAN HAMSTER; THERAPY EFFECT; TISSUE INJURY; TISSUE OXYGENATION; TISSUE PERFUSION; TREATMENT OUTCOME; TREATMENT RESPONSE; VASCULARIZATION;

ANIMALS; CRICETINAE; CRITICAL ILLNESS; ERYTHROPOIETIN, RECOMBINANT; HUMANS; ISCHEMIA; MALE; MESOCRICETUS; MICROCIRCULATION; NITRIC OXIDE SYNTHASE; OXYGEN; REGIONAL BLOOD FLOW; SURGICAL FLAPS;

EID: 68049094179     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e31818b9cc4     Document Type: Article

References (48)

1. Piper RD, Pitt-Hyde ML, Anderson LA, Sibbald WJ, Potter RF: Leukocyte activation and flow behavior in rat skeletal muscle in sepsis. Am J Respir Crit Care Med 157:129-134, 1998.
2. Nakagawa NK, Nogueira RA, Correia CJ, Shiwa SR, Costa Cruz JW, Poli de Figueiredo LF, Roca E, Silva M, Sannomiya P: Leukocyte-endothelium interactions after hemorrhagic shock/reperfusion and cecal ligation/puncture: an intravital microscopic study in rat mesentery. Shock 26:180-186, 2006.
3. Bersten A, Sibbald WJ: Circulatory disturbances in multiple systems organ failure. Crit Care Clin 5:233-254, 1989.
4. Lam C, Tyml K, Martin C, Sibbald W: Microvascular perfusion is impaired in a rat model of normotensive sepsis. J Clin Invest 94:2077-2083, 1994.
5. Hoffmann JN, Vollmar B, Inthorn D, Schilberg FW, Menger MD: A chronic model for intravital microscopic study of microcirculatory disorders and leukocyte/endothelial cell interaction during normotensive endotoxemia. Shock 12:355-364, 1999.
6. Dietrich HH, Tyml K: Capillary as a communicating medium in the microvasculature. Microvasc Res 43:87-99, 1992.
7. Koller A, Kaley G: Endothelial regulation of wall shear stress and blood flow in skeletal muscle microcirculation. Am J Physiol 260:H862-H868, 1991.
8. Hoffmann JN, Vollmar B, Laschke MW, Inthorn D, Fertmann J, Schilberg FW, Menger MD: Microhemodynamic and cellular mechanisms of activated protein C action during endotoxemia. Crit Care Med 32:1011-1017, 2004.
9. Bartolome S, Wood JG, Casillan AJ, Simpson SQ, O'Brien-Ladner AR: Activated protein C attenuates microvascular injury during systemic hypoxia. Shock 29:384-387, 2008.
10. De Backer D: Benefit-risk assessment of drotrecogin alfa (activated) in the treatment of sepsis. Drug Saf 30:995-1010, 2007.
11. Chong ZZ, Kang JQ, Maiese K: Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases. Circulation 106:2973-2979, 2002.
12. Anagnostou A, Lee ES, Kessimian N, Levinson R, Steiner M: Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc Natl Acad Sci U S A 87:5978-5982, 2002.
13. Contaldo C, Meier C, Elsherbiny A, Harder Y, Trentz O, Menger MD, Wanner GA: Human recombinant erythropoietin protects the striated muscle microcirculation of the dorsal skinfold from postischemic injury in mice. Am J Physiol Heart Circ Physiol 293:H274-283, 2007.
14. Abdelrahman M, Sharples EJ, McDonald MC, Collin M, Patel NS, Yaqoob MM, Thiemermann C: Erythropoietin attenuates the tissue injury associated with hemorrhagic shock and myocardial ischemia. Shock 22:63-69, 2004.
15. Urao N, Okigachi M, Yamada H, Aadachi Y, Matsuno K, Matsui A, Matsunaga S, Tateishi K, Nomura T, Takahashi T, et al.: Erythropoietin-mobilized endothelial progenitors enhance reendothelialisation via Akt-endothelial nitric oxide synthase activation and prevent neointimal hyperplasia. Circ Res 98:1405-1413, 2006.
16. d'Uscio LV, Smith LA, Santhanam AV, Richardson D, Nath KA, Katusic ZS: Essential role of endothelial nitric oxide synthase in vascular effects of Erythropoietin. Hypertension 49:1142-1148, 2007.
17. Beleslin-Cokic BB, Cokic VP, Yu X, Weksler BB, Schechter AN, Noguchi CT: Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells. Blood 104:2073-2080, 2004.
18. Lindenblatt N, Menger MD, Klar E, Vollmar B: Darpoietin-alpha does not promote microvascular thrombus formation in mice: role of eNOS dependent protection through platelet and endothelial cell deactivation. Arterioscler Thromb Vasc Biol 27:1191-1198, 2007.
19. Cuzzocrea S, Mazzon E, Di Paola R, Patel NS, Genovese T, Muia C, De Sarro A, Thiemermann C: Erythropoietin reduces the development of experimental inflammatory bowel disease. J Pharmacol Exp Ther 311:1272-1280, 2004.
20. Cuzzocrea S, Di Paola R, Mazzon E, Patel NS, Genovese T, Muia C, Crisafulli C, Caputi AP, Thiemermann C: Erythropoietin reduces the development of nonseptic shock induced by zymosan in mice. Crit Care Med 34:1168-1177, 2006.
21. Le Minh K, Klemm K, Abshagen K, Eipel C, Menger MD, Vollmar B: Attenuation of inflammation and apoptosis by pre- and posttreatment of darpoietin-(alpha) in acute liver failure of mice. Am J Pathol 170:1954-1963, 2007.
22. Contaldo C, Plock J, Sakai H, Takeoka S, Tsuchida E, Leunig M, Banic A, Erni D: New generation of haemoglobin-based oxygen carriers evaluated for oxygenation of critically ischemic hamster flap tissue. Crit Care Med 33:817-822, 2005.
23. 2 affinity. J Physiol Heart Circ Physiol 285:H1140-H1147, 2003.
24. Baker M, Wayland H: On-line volume flow rate and velocity profile measurement for blood in microvessels. Microvasc Res 7:131-143, 1974.
25. Menger MD, Pelikan S, Steiner D: Microvascular ischemia/reperfusion injury in striated muscle: significance of "reflow-paradox". Am J Physiol 263:H1901-H1906, 1992.
26. Dangerfield JP, Wang S, Nourshargh S: Integrin inhibits IL-1beta- but not TNF-alpha-induced neutrophil transmigration in vivo. J Leukoc Biol 77:159-165, 2005.
27. Chierego M, Verdant C, De Backer D: Microcirculatory alterations in critically ill patients. Minerva Anestesiol 72:199-205, 2006.
28. Cryer HM, Garrison RN, Kaebnick HW, Harris PD, Flint LM: Skeletal microcirculatory responses to hyperdynamic Escherichia coli sepsis in unanesthetized rats. Arch Surg 122:86-92, 1987.
29. Ellis CG, Jagger J, Sharpe M: The microcirculation as a functional system. Crit Care 9(suppl 4):S3-S8, 2005.
30. Bateman RM, Sharpe MD, Ellis CG: Bench-to-bedside review: microvascular dysfunction in sepsis-hemodynamics, oxygen transport, and nitric oxide. Crit Care 7:359-373, 2003.
31. Gute DC, Ishida T, Yarimizu K, Korthuis RJ: Inflammatory responses to ischemia and reperfusion in skeletal muscle. Mol Cell Biochem 179:169-187, 1998.
32. Jerome SN, Smith CW, Korthuis RJ: CD18-dependent adherence reactions play an important role in the development of the no-reflow phenomenon. Am J Physiol Heart Circ Physiol 264:H479-H483, 1993.
33. Bateman RM, Jagger JE, Sharpe MD, Ellsworth ML, Metha S, Ellis CG: Erythrocyte deformability is a nitric oxide-mediated factor in decreased capillary density during sepsis. Am J Physiol Heart Circ Physiol 280:H2848-H2856, 2001.
34. Levi M, de Jonge E, van der Poll T: Sepsis and disseminated intravascular coagulation. J Thromb Thrombolysis 16:43-47, 2003.
35. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, et al.: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:699-709, 2001.
36. Suematsu M, DeLano FA, Poole D, Engler RL, Miyasaka M, Zweifach BW, Schmid-Schönbein GW: Spatial and temporal correlation between leukocyte behavior and cell injury in postischemic rat skeletal muscle microcirculation. Lab Invest 70:684-695, 1994.
37. Erni D, Sakai H, Tsai AG, Banic A, Sigurdsson GH, Intaglietta A: Haemodynamics and oxygen tension in the microcirculation of ischaemic skin flaps after neural blockade and haemodilution. Br J Plast Surg 52:565-572, 1999.
38. Muller WA, Randolph GJ: Migration of leukocytes across endothelium and beyond: molecules involved in the transmigration and fate of monocytes. J Leukoc Biol 66:698-704, 1999.
39. Peterson TE, Katusic ZS: EPO tecting the endothelium. Br J Pharmacol 150:823-825, 2007.
40. Brines M, Grasso G, Fiordaliso F, Sfacteria A, Ghezzi P, Fratelli M, Latini R, Xie QW, Smart J, Su-Rick CJ, et al.: Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. Proc Natl Acad Sci U S A 101:14907-14912, 2004.
41. Arnal JF, Dinh-Xuan AT, Pueyo M, Darblade B, Rami J: Endothelium-derived nitric oxide and vascular physiology and pathology. Cell Mol Life Sci 55:1078-1087, 1999.
42. Kubes P, Kurose I, Granger DN: NO donors prevent integrin-induced leukocyte adhesion but not P-selectin-dependent rolling in postischemic venules. Am J Physiol 267:H931-H937, 1994.
43. Fisher JW: Erythropoietin: physiology and pharmacology update. Exp Biol Med 228:1-14, 2003.
44. Villa P, Bigini P, Mennini T, Agnello D, Laragione T, Cagnotto A, Viviani B, Marinovivh M, Cerami A, Coleman TR, et al.: Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J Exp Med 198:971-975, 2003.
45. Dimmeler S, Zeiher AM: Nitric oxide and apoptosis: another paradigm for the double-edged role of nitric oxide. Nitric Oxide 1:275-281, 1997.
46. Rossig L, Fichtlscherer B, Breitschopf K, Haendeler J, Zeiher AM, Mülsch A, Dimmeler S: Nitric oxide inhibits caspase-3 by S-nitrosation in vivo. J Biol Chem 274:6823-6826, 1999.
47. Newman PJ, Newman DK: Signal transduction pathways mediated by PECAM-1: new roles for an old molecule in platelet and vascular cell biology. Arterioscler Thromb Vasc Biol 23:953-964, 2003.
48. Bogen S, Pak J, Garifallou M, Deng X, Muller WA: Monoclonal antibody to murine PECAM-1 (CD31) blocks acute inflammation in vivo. J Exp Med 179:1059-1064, 1994.